A Defining Moment for Ophthalmology Innovation

The American Academy of Ophthalmology (AAO) annual meeting has always been the leading
forum for innovation and clinical progress in eye care. But AAO 2025, held in Orlando, marked a
clear shift in focus, from incremental improvement to intelligent transformation.
AI, automation, and integration moved from buzzwords to baselines, reflecting a profession
ready to reimagine how care is delivered.

Across exhibitor booths, the conversations centered on one truth: Ophthalmology is entering
an intelligent era—where data, design, and decision-support converge to empower both
providers and patients.

For technology leaders like Optivate (formerly known as EyeMD EMR Healthcare Systems), AAO
2025 was more than a showcase. It was a validation that the specialty is ready for fully
connected ecosystems, AI-enhanced documentation, and purpose-built solutions that simplify
clinical and operational complexity.

AI dominated the show floor. Every conversation, from booth demos to panel Q&As, gravitated
toward its potential to solve ophthalmology’s greatest challenge: time.

Providers shared stories of burnout from administrative work and charting redundancy. AI
emerged not as a futuristic ideal but as a practical answer to a familiar question:
How can we give clinicians time back for care?

Attendees described AI as “a game-changer” for practice efficiency, especially when embedded
directly into clinical workflows. From real-time transcription to diagnostic image interpretation,
the message was clear, AI belongs inside the software, not outside it.

And that alignment, AI meeting ophthalmology where it already works, became one of AAO
2025’s most important takeaways.

The leap from curiosity to commitment was unmistakable. In 2024, conversations about AI
were speculative; in 2025, they were strategic. Physicians wanted to understand not if they
should adopt AI, but how soon. Surveys and booth feedback revealed that more than two-thirds
of visitors now view AI as a core component of the clinical workflow, not just an add-on.

Key drivers fueling AI adoption include:
● Time Efficiency: AI-driven charting and speech-to-text tools free up time, allowing clinicians to see more
patients and reduce after-hours documentation.
● Accuracy & Compliance: Intelligent documentation reduces human error, automatically capturing key clinical
data points needed for billing and quality reporting.
● Enhanced Patient Experience: When physicians spend less time at screens, patient engagement improves—an
increasingly critical differentiator for private practices.
As one attendee put it,

“AI isn’t replacing the physician; it’s replacing the friction that slows the physician down.”

AAO 2025 underscored the industry’s continued move away from siloed systems. For years,
ophthalmologists have juggled multiple platforms including EMR, practice management,
imaging, billing, and patient engagement, with each operating in isolation. This fragmentation
created inefficiencies and data gaps that hindered coordinated care.
The takeaway this year: integration isn’t a feature; it’s a foundation.

Practices now demand platforms that deliver:
● Unified data flows between EMR, PM, patient engagement, and RCM software and
workflows.
● Single-screen visibility for clinical, financial, and patient-communication metrics.
● Automated hand-offs between technicians, providers, and billing teams.

Ophthalmology-specific vendors demonstrated that “all-in-one” no longer means compromise.
When integration is designed intentionally, it produces measurable gains in both revenue and
satisfaction.

Optivate’s connected ecosystem, built for ophthalmology from the ground up, illustrates how
seamless integration can free staff from administrative drag while giving leaders better
analytics for growth.

Another clear takeaway was specialization. Multi-specialty EMRs may cover general workflows,
but they rarely capture the nuance of ophthalmology’s diagnostic precision.
Attendees expressed renewed appreciation for systems designed for their field, by their field.

The specialty-specific model offers advantages that resonated throughout AAO 2025:

● Purpose-built Templates tailored to eye-care exams and imaging workflows.
● Software Integrations that communicate seamlessly with diagnostic equipment.
● Terminology Alignment matching ophthalmology’s clinical language and billing codes.
● Dedicated Support Teams trained in the unique needs of ophthalmology practices.
As one administrator noted during a breakout session,

“Multi-specialty software treats ophthalmology like a checkbox. Ophthalmology-specific
software treats it like a craft.”

This emphasis on craft and purpose-driven technology underscored the growing maturity of
ophthalmology’s digital transformation.

AAO 2025 marked a defining moment for EyeMD EMR Healthcare Systems — now known as
Optivate. The event served as the first major platform to showcase the company’s evolving
identity — one that reflects a broader vision for ophthalmology innovation and intelligent,
connected care.

While some attendees initially approached the booth curious about the new name, the
transition quickly became a catalyst for conversation. Once they experienced the familiar team,
product excellence, and unified platform behind the new identity, curiosity turned to familiar
deep confidence.

The name Optivate embodies the company’s mission: to optimize care and elevate what
matters. It signifies a next chapter built on the trusted legacy of EyeMD EMR, now expanded to
include advanced AI capabilities, seamless workflow integration, and a refined user experience
tailored to ophthalmology.

Feedback from both current clients and new prospects was overwhelmingly positive. Many
described the rebrand as “modern,” “professional,” and ““exactly what the market was waiting
for.” Existing customers expressed confidence that the transition represents growth, not
replacement, and that the people and values behind EyeMD EMR remain unchanged.

“The new name feels like a natural evolution,” one long-time client noted. “It shows the
company has matured and is ready for the next era of intelligent ophthalmology technology.”

This rebrand conversation became one of AAO 2025’s most memorable themes, reinforcing
that Optivate isn’t just a new name; it’s a commitment to clarity, innovation, and long-term
partnership in eye care.

Despite the focus on automation, AAO 2025 reminded everyone that technology’s value
depends on human connection. The most visited booths weren’t necessarily those with the
flashiest AI demos, but those with engaged, knowledgeable teams who could translate
innovation into outcomes.

At Optivate’s booth, the synergy between product specialists, sales leaders, and clinicians
created authentic dialogue. Visitors sensed alignment between what the brand promised and
what its people delivered. This underscores a broader lesson for all vendors and practices alike:
Innovation succeeds when it enhances relationships, not replaces them.

As conversations wound down in Orlando, one consensus remained: the next wave of
ophthalmology technology will center on adaptive systems that learn from real-world data.
Next-generation systems will not only automate tasks but also anticipate needs, offering
proactive recommendations based on data patterns across the entire patient lifecycle.

Emerging directions discussed at AAO 2025 include:
● Predictive Analytics for disease progression and resource planning.
● AI-Assisted Imaging Interpretation that triages abnormal scans for physician review.
● Deeper Voice-Driven Workflows integrated more deeply into mobile apps for hands-
free charting.
● Cross-Platform Data Exchange between surgical centers, diagnostic devices, and patient
engagement tools.

Optivate has already begun exploring these innovations, ensuring that future releases build on
real-world ophthalmology feedback rather than generic AI prototypes.

For practice owners and administrators who couldn’t attend AAO 2025, several actionable
insights emerged:

Let’s explore how Optivate can streamline your workflows and prepare your practice for the
intelligent future of eye care.

Book Your Consultation

What’s next for ophthalmology technology after AAO 2025?
Expect deeper AI integration across imaging, documentation, and analytics; stronger
interoperability between systems; and a continued shift toward all-in-one, specialty-specific
platforms.

What was the main theme of AAO 2025?
AAO 2025 focused on intelligent, connected technology, especially AI integration, workflow
automation, and the convergence of clinical and administrative systems.

Why is AI so important for ophthalmology right now?
AI addresses documentation burden, improves diagnostic accuracy, and enhances patient
communication. As practices face staffing shortages, increasing costs, and tightening
regulations, AI delivers meaningful time savings without compromising care quality.

What did Optivate (f/k/a as EyeMD EMR Healthcare Systems) highlight at AAO 2025?
Optivate showcased its evolving AI-driven platform and introduced its new brand identity.
The company demonstrated how integrated EMR, PM, and patient-engagement solutions
simplify daily workflows for ophthalmology practices.

How did attendees respond to the rebrand from EyeMD EMR to Optivate?
Feedback was overwhelmingly positive. Attendees described the new identity as modern,
confident, and reflective of the company’s growth and long-term commitment to
ophthalmology.

With summer in the rearview mirror and students back in classrooms, it’s the perfect time to refocus on your 2025 MIPS goals. Your Verana IRIS dashboard will continue to refresh monthly, giving you the latest data to guide your performance. Hopefully, your recent check-in with your Verana Practice Experience Manager (PEM) helped you fine-tune your strategy for success.

As we move into the second half of the year, let’s review the critical milestones and updates that will help you finish strong.

January 1, 2025 – Start of the 2025 MIPS performance period for Quality and Cost

May 2025* – Verana will update dashboards with 2025 Quality data

May 31, 2025* – Deadline to Register with Verana for 2025 participation and select service level

June 2025 – Final 2024 MIPS scores released on the QPP website

June 15, 2025* – Deadline to Register for EHR Integration with IRIS Registry

July 5, 2025 – Last day to start the 180-day Promoting Interoperability (PI) performance period

August 1, 2025* – Last day to notify Verana Health about changes to EHR or data system (system upgrade, moving to the cloud or new system)

October 3, 2025 – Last day to begin a 90-day Improvement Activity (IA) performance period

October 31, 2025* – Deadline to Submit Mapping Requests to Verana Health

December 31, 2025 –End of the 2025 MIPS performance period

Deadline to submit an Extreme & Uncontrollable Hardship Application or a Promoting Interoperability Exemption

Final day to complete the Security Risk Analysis (SRA) and SAFER Guide for 2025

* Verana deadline dates are subject to change

CMS has made some notable adjustments for the 2025 reporting year, especially for EyeMD EMR users.

The IA_EPA_1 activity — Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient’s Medical Record — is being retired. This was one of the easiest and most common activities, so you’ll need to choose and document a new Improvement Activity for a minimum of 90 consecutive days in 2025.

Key requirement: At least 50% of your MIPS-eligible providers must actively perform the selected Improvement Activity during the performance period. It is the practice’s responsibility to maintain thorough documentation to prove compliance in the event of a CMS audit.

Before 2025:

Starting 2025:

If your practice has 16 or fewer providers, you’ll continue to benefit from MIPS flexibilities, including:

 Only 1 IA required (no weighting)

 6 bonus points for reporting at least one Quality Measure

 Automatic Promoting Interoperability exemption with points redistributed to other categories (still eligible for bonuses)

 3 points awarded for Quality Measures that don’t meet completeness, case minimums, or benchmarks

Practices in HPSAs or Rural Areas may be eligible for extra support

FHIR is a required part of MIPS Promoting Interoperability (PI), but its importance goes beyond MIPS reporting. If your practice attested for PI last year, FHIR should already be enabled—please make sure this is the case.

Even if you’re not planning to attest to PI for 2025, your practice is still expected to make a FHIR API available for patient-authorized apps. FHIR also supports compliance with the 21st Century Cures Act and the Information Blocking Rule by enabling standardized, API-based data sharing. Failure to comply can result in enforcement action s, financial penalties, and reputational risks under ONC and OIG oversight.

We’ll be sharing more detailed guidance on FHIR in an upcoming newsletter, so keep an eye out for that update.

To enable FHIR for your practice, please contact Customer Service:
 CS@EyeMDEMR.com
 877-239-3367 (Option 2)

To stay ahead of the curve, make sure to:

 Select your 2025 Improvement Activity and begin no later than October 2, 2025
 Start working on your Security Risk Analysis (SRA) early
 Meet with your Verana PEM to review your dashboard and ensur e progress is on track
 Submit any mapping requests to Verana before the October 31, 2025, deadline

 If you haven’t already, contact Customer Service to enable FHIR.

Have questions about MIPS requirements or navigating your Verana dashboard?
Contact your Verana Practice Experience Manager (PEM) or the EyeMD EMR Training team at 877-239-3367, option 4 for guidance and support.

Spring has sprung, which means it’s time to start your 2025 MIPS planning and monitoring. If you haven’t already scheduled an appointment with your Verana Practice Experience Manager, now is the time to do so. Additionally, this year Verana is requiring registration to verify practice details and select a service level. Please review details on Verana’s new service level selection and be sure to register by May 31, 2025.

January 1, 2025 – Start of the 2025 MIPS performance period for Quality and Cost

May 2025* – Verana will update dashboards with 2025 Quality data

May 31, 2025* – Deadline to Register with Verana for 2025 participation and select service level

June 2025 – Final 2024 MIPS scores released on the QPP website

June 15, 2025* – Deadline to Register for EHR Integration with IRIS Registry

July 5, 2025 – Last day to start the 180-day Promoting Interoperability (PI) performance period

August 1, 2025* – Last day to notify Verana Health about changes to EHR or data system (system upgrade, moving to the cloud or new system)

October 3, 2025 – Last day to begin a 90-day Improvement Activity (IA) performance period

October 31, 2025* – Deadline to Submit Mapping Requests to Verana Health

December 31, 2025 – End of the 2025 MIPS performance period

Deadline to submit an Extreme & Uncontrollable Hardship Application or a Promoting Interoperability Exemption

Final day to complete the Security Risk Analysis (SRA) and SAFER Guide for 2025

* Verana deadline dates are subject to change

Several updates to the 2025 MIPS reporting year may impact your practice. The most significant change for EyeMD EMR users is the retirement of IA_EPA_1: Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient’s Medical Record. This was one of the most widely used and easily met activities. With its retirement, it is critical to select and document a new Improvement Activity for at least 90 consecutive days in 2025.

Additionally, CMS has eliminated weighting for Improvement Activities. Previously, practices had to complete:

For 2025, all activities carry equal weight:

Practices with 16 or fewer providers continue to receive MIPS support, including:

 Only 1 IA required (no weighting applied)
 6 bonus points for reporting at least one Quality Measure
 Automatic exemption from Promoting Interoperability (PI) with points reallocated to other categories (while remaining eligible for bonuses)
 3 points for Quality Measures that do not meet full data completeness, case minimums (20 patients), or benchmarks

Practices in designated Health Professional Shortage Areas (HPSAs) and Rural Areas may receive additional support.

While this newsletter focuses on MIPS requirements, we also want to highlight the upcoming 2025 requirements for FHIR API connectivity.

If you attested to PI in the past year, you should already have activated the FHIR API. However, if you haven’t attested to PI, this may be a new term for you. Learn more about FHIR and its impact on your practice 21st Century Cures Act and Information Blocking Rule.

For 2025 PI attestation, FHIR activation is mandatory. Without it, you cannot report PI. Even if you do not plan to report PI, you will still need FHIR activation to comply with upcoming payer requirements, which will reduce administrative burden and streamline claims payments and authorizations. This transition will start with CMS and expand rapidly to private payers.

To enable FHIR API for your practice, please contact Customer Service:

 CS@EyeMDEMR.com
 877-239-3367 (Option 2)

 Review the Improvement Activities list and select an activity that fits your practice
 Decide whether to attest to PI for 2025 – If yes, schedule a PI meeting with your EyeMD Trainer and start working on the High-Priority SAFER Guide
 Begin work on the Security Risk Analysis (SRA)

If you have any questions regarding MIPS or navigating your Verana dashboard, don’t hesitate to contact your Verana Practice Experience Manager or the EyeMD EMR Training team.